Increased risk of gastrointestinal malignancy in patients with diabetes mellitus and correlations with anti-diabetes drugs: a nationwide population-based study in Taiwan.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Internal medicine

• Publication date

  2013-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2169/INTERNALMEDICINE.52.8276PMID 23648711
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antidiabetes drugs correlate with decreased risk of lung cancer: a population-based observation in Taiwan.

  2012cited by this paper
• Diabetes mellitus correlates with increased risk of pancreatic cancer: A population‐based cohort study in Taiwan

  2012cited by this paper
• Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus

  2012cited by this paper
• Increased risk of ischemic stroke in patients with systemic lupus erythematosus: a nationwide population-based study.

  2012cited by this paper
• Risk of Malignant Neoplasm of the Pancreas in Relation to Diabetes

  2011cited by this paper
• Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort.

  2011cited by this paper
• Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals

  2011cited by this paper
• Risk factors of Helicobacter pylori infection among adults in northern China.

  2011cited by this paper
• Cancer Risk Associated with Insulin Glargine among Adult Type 2 Diabetes Patients – A Nationwide Cohort Study

  2011cited by this paper
• Diabetes mellitus and increased risk of biliary tract cancer: systematic review and meta-analysis

  2011cited by this paper
• Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies.

  2011cited by this paper
• Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death

  2011cited by this paper
• Statin use in patients with asthma – a nationwide population‐based study

  2011cited by this paper
• Angiotensin II receptor blockers and risk of cancer in patients with systemic hypertension.

  2011cited by this paper
• Diabetes mellitus, fasting glucose, and risk of cause-specific death.

  2011cited by this paper
• Prospective study reveals associations between colorectal cancer and type 2 diabetes mellitus or insulin use in men.

  2010cited by this paper
• Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes: ZODIAC-16

  2010cited by this paper
• Linking diabetes and cancer: a consensus on complexity.

  2010cited by this paper
• Substantially increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis of epidemiologic evidence in Japan.

  2010cited by this paper
• Thiazolidinediones inhibit hepatocarcinogenesis in hepatitis B virus–transgenic mice by peroxisome proliferator‐activated receptor γ–independent regulation of nucleophosmin

  2010cited by this paper
• JNK-mediated transcriptional upregulation of RhoB is critical for apoptosis of HCT-116 colon cancer cells by a novel diarylsulfonylurea derivative

  2010cited by this paper
• Risk of adverse outcomes in Taiwan associated with concomitant use of clopidogrel and proton pump inhibitors in patients who received percutaneous coronary intervention.

  2010cited by this paper
• Pioglitazone, a ligand for peroxisome proliferator-activated receptor-γ acts as an inhibitor of colon cancer liver metastasis

  2010cited by this paper
• Diabetes and Cancer

  2010cited by this paper
• Diabetes and Cancer: A Consensus Report

  2010influential reference
• Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes

  2009cited by this paper
• Do diabetes drugs modify the risk of pancreatic cancer?

  2009cited by this paper
• Diabetes mellitus as a risk factor for gastrointestinal cancer among American veterans.

  2009cited by this paper
• The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

  2009cited by this paper
• New Users of Metformin Are at Low Risk of Incident Cancer

  2009cited by this paper
• Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study

  2009cited by this paper
• Insulin glargine and malignancy: an unwarranted alarm.

  2009cited by this paper
• Rosiglitazone and Risk of Cancer

  2008cited by this paper
• Pioglitazone, a ligand for peroxisome proliferator-activated receptor-gamma acts as an inhibitor of colon cancer liver metastasis.

  2008cited by this paper
• Role of the integrin αVβ3 in mediating increased smooth muscle cell responsiveness to IGF-I in response to hyperglycemic stress

  2007cited by this paper
• Role of the integrin alphaVbeta3 in mediating increased smooth muscle cell responsiveness to IGF-I in response to hyperglycemic stress.

  2007cited by this paper
• Metformin and reduced risk of cancer in diabetic patients

  2005cited by this paper
• Diabetes mellitus: a risk factor for pancreatic cancer?

  2005cited by this paper
• Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance.

  2004cited by this paper
• Taiwan's new national health insurance program: genesis and experience so far.

  2003cited by this paper
• Rising prevalence of diabetes: evidence from a Danish pharmaco-epidemiological database.

  2003cited by this paper
• The role of diabetes in hepatocellular carcinoma: a case-control study among United States veterans

  2001cited by this paper
• Global and societal implications of the diabetes epidemic

  2001cited by this paper
• DoesHelicobacter pylori-induced gastritis enhance food-stimulated insulin release?

  1996cited by this paper
• Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis.

  1995cited by this paper
• Insulin-like Growth Factors and Cancer

  1995cited by this paper
• Insulin and colon cancer

  1995cited by this paper
• A case-control study of diabetes mellitus and cancer risk.

  1994cited by this paper
• Insulin-like growth factors and cancer.

  1992cited by this paper
• Growth-stimulatory actions of insulin in vitro and in vivo.

  1984cited by this paper
• Coronary atherosclerosis and myocardial infarction associated with systemic lupus erythematosus.

  1974cited by this paper
• Influence of insulin deprivation on growth of the 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in rats subjected to alloxan diabetes and food restriction.

  1972cited by this paper

• Risk factors for cancer among patients with type 2 diabetes: a retrospective cohort study

  2025cites this paper
• Alpha-Glucosidase Inhibitors in Aging and Aging-Related Diseases: Clinical Applications and Relevant Mechanisms

  2024cites this paper
• Acarbose might be associated with reduced risk of gastric cancer in patients with diabetes mellitus: A nationwide population‐based cohort study

  2024cites this paper
• Hypoglycemic agents and incidence of pancreatic cancer in diabetic patients: a meta-analysis

  2023influential citation
• Use of Antihyperglycemic Drugs and Risk of Cancer in Patients with Diabetes

  2022cites this paper
• The Relationship between Diabetes Mellitus and Gastric Cancer and the Potential Benefits of Metformin: An Extensive Review of the Literature

  2021cites this paper
• A Novel Diagnostic Biomarker, PZP, for Detecting Colorectal Cancer in Type 2 Diabetes Mellitus Patients Identified by Serum-Based Mass Spectrometry

  2021cites this paper
• Thiazolidinediones, alpha-glucosidase inhibitors, Meglitinides, sulfonylureas, and hepatocellular carcinoma risk: a meta-analysis.

  2021cites this paper
• A Cohort Study of Antihyperglycemic Medication Exposure and Gastric Cancer Risk

  2020cites this paper
• DMSO_A_251063 1763..1770

  2020cites this paper
• Nomogram for Predicting Risk of Digestive Carcinoma Among Patients with Type 2 Diabetes

  2020cites this paper
• The medications and health care utilization of patients newly diagnosed with type 2 diabetes mellitus: A nationwide population-based cohort study.

  2020cites this paper
• Classification of Cancer for Type 2 Diabetes Using Machine Learning Algorithm

  2020cites this paper
• Type 2 diabetes mellitus and gastrointestinal cancer : Disease, drugs, or distortion?

  2019cites this paper
• A cohort study of antihyperglycemic medication exposure and survival in patients with gastric cancer

  2019cites this paper
• Synchronous colorectal carcinoma: predisposing factors and characteristics

  2019cites this paper
• The influence of diabetes and antidiabetic medications on the risk of pancreatic cancer: a nationwide population-based study in Korea

  2018cites this paper
• Development of a Prediction Model for Colorectal Cancer among Patients with Type 2 Diabetes Mellitus Using a Deep Neural Network

  2018cites this paper
• Association between insulin therapy and risk of liver cancer among diabetics: a meta-analysis of epidemiological studies

  2018cites this paper
• Gastrointestinal cancer incidence in type 2 diabetes mellitus; results from a large population-based cohort study in the UK.

  2018cites this paper
• Epidemiological dimensions of the association between type 2 diabetes and cancer: A review of observational studies.

  2018cites this paper
• Psoriasis and cancer. An Australian/New Zealand narrative

  2018cites this paper
• Thiazolidinediones and risk of colorectal cancer in patients with diabetes mellitus: A meta-analysis

  2018cites this paper
• Application of Marginal Structural Models with Inverse Probability of Treatment Weighting in Electronic Health Records to Investigate the Benefits and Risks of First Line Type II Diabetes Treatments.

  2017cites this paper
• Prognostic significance of anti-diabetic medications in pancreatic cancer: A meta-analysis

  2017cites this paper
• Insulin Resistance: Any Role in the Changing Epidemiology of Thyroid Cancer?

  2017cites this paper
• Diabetes Mellitus and Risk of Hepatocellular Carcinoma

  2017cites this paper
• Diabetes-induced mechanophysiological changes in the small intestine and colon

  2017cites this paper
• Alpha-glucosidase inhibitors and risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis

  2017influential citation
• Diabetes drugs and the incidence of solid cancers: a survey of the current evidence

  2017cites this paper
• Meta-analysis of studies using metformin as a reducer for liver cancer risk in diabetic patients

  2017cites this paper
• No Decreased Risk of Gastrointestinal Cancers in Users of Metformin in The Netherlands; A Time-Varying Analysis of Metformin Exposure

  2017cites this paper
• Metformin and cancer in type 2 diabetes: a systematic review and comprehensive bias evaluation

  2017cites this paper
• Mortality and causes of death in a national sample of type 2 diabetic patients in Korea from 2002 to 2013

  2016cites this paper
• Metformin and cancer in type 2 diabetes: a systematic review and comprehensive bias evaluation

  2016cites this paper
• Diabetes mellitus increases the risk of colorectal neoplasia: An updated meta-analysis.

  2016cites this paper
• An overview on understanding the main factors involved in colon cancer and its treatment

  2015cites this paper
• Use of an α-Glucosidase Inhibitor and the Risk of Colorectal Cancer in Patients With Diabetes: A Nationwide, Population-Based Cohort Study

  2015cites this paper
• The Impact of Diabetes Mellitus and Metformin Treatment on Survival of Patients with Advanced Pancreatic Cancer Undergoing Chemotherapy

  2015cites this paper
• Metformin may improve the prognosis of patients with pancreatic cancer.

  2015influential citation
• Insulin and other antidiabetic drugs and hepatocellular carcinoma risk: a nested case‐control study based on Italian healthcare utilization databases

  2015cites this paper
• Cancer risks among the users of ergot-derived dopamine agonists for Parkinson's disease, a nationwide population-based survey.

  2015influential citation
• Impact des ligands de PPARs, et leurs dérivés, sur les cellules cancéreuses coliques humaines : modifications des statuts redox et glycolytique

  2014cites this paper
• Diabetes Mellitus as a Novel Risk Factor for Gastrointestinal Malignancies

  2014cites this paper
• Tumor Macroenvironment and Metabolism

  2014cites this paper
• Antihyperglycaemic therapies and cancer risk

  2014cites this paper
• Diabetes and pancreatic cancer.

  2014cites this paper
• Effects of Metformin on CD133+ Colorectal Cancer Cells in Diabetic Patients

  2013cites this paper
• Diabetes and pancreatic cancer.

  2013cites this paper
• EPIDEMIOLOGÍA DESCRIPTIVA DEL CÁNCER DE PÁNCREAS EXOCRINO EN LA COMUNIDAD DE MADRID. ANÁLISIS DE SUPERVIVENCIA.

  2013cites this paper
• Epidemiological and Experimental Studies : The Role of Metformin on Colorectal Cancer

  year unknowncites this paper